Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 2/20 | 0.38 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30945319 | 1.00 | TSHR (0.48) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL10353692 | 0.90 | TSHR (0.43) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL15354544 | 0.80 | TSHR (0.48) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL3087524 | 0.79 | TSHR (0.41) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL2227750 | 0.79 | TSHR (0.48) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL18000477 | 0.76 | TSHR (0.47) | TSHRALDH1A1TDP1LMNAHSD17B10 | |
| SCHEMBL12275570 | 0.76 | TSHR (0.45) | TSHRALDH1A1TDP1ACHECYP3A4 | |
| SCHEMBL31536932 | 0.76 | HSD17B10 (0.48) | TSHRALDH1A1TDP1ACHELMNA | |
| SCHEMBL345760 | 0.76 | HSD17B10 (0.48) | TSHRALDH1A1TDP1ACHELMNA | |
| SCHEMBL1424323 | 0.76 | TSHR (0.45) | TSHRALDH1A1TDP1ACHECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326709-A1 | THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS | PURDUE RESEARCH FOUNDATION (US) | 2025-10-23 | — | — | US | claimed |
| WO-2025059054-A1 | PROCESS FOR PREPARING (2S,4S,4'S,6S)-2-METHYL-6-(1-METHYL-1H-1,2,3-TRIAZOL-4-YL)-2',-(TRIELUOROMETHYL)-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO [2,3-C] PYRAN] -4'-OL | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-03-20 | — | — | WO | claimed |
| CN-115197046-B | Halogenation method of unsaturated hydrocarbon | 华南理工大学 | 2023-12-15 | — | — | CN | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| EP-0397474-B1 | Photosensitive composition | TOSHIBA KK (JP) | 1997-12-10 | — | — | EP | claimed |
| US-5100768-A | Photoresists for integrated circuits, polyvinyl phenol and nitrogen containing heterocycle | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-03-31 | — | — | US | claimed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | claimed |
| CN-122059908-A | Method for preparing propylene oxide by catalyzing propylene air epoxidation through double metal-free catalysts | 浙江工业大学 | 2026-05-19 | — | — | CN | disclosed |
| US-20250326709-A1 | THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS | PURDUE RESEARCH FOUNDATION (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4619048-A1 | CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS | Ustav Organicke Chemie a Biochemie AV CR v.v.i. (CZ) | 2025-09-24 | — | — | EP | disclosed |
| WO-2025059054-A1 | PROCESS FOR PREPARING (2S,4S,4'S,6S)-2-METHYL-6-(1-METHYL-1H-1,2,3-TRIAZOL-4-YL)-2',-(TRIELUOROMETHYL)-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO [2,3-C] PYRAN] -4'-OL | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2024120557-A1 | CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS | Ustav Organicke Chemie A Biochemie AV CR v.v.i. (CZ) | 2024-06-13 | — | — | WO | disclosed |
| EP-0175464-A1 | Benzimidazole derivatives and their production | Takeda Chemical Industries, Ltd. (JP) | 1986-03-26 | — | — | EP | disclosed |
| EP-0138983-A4 | N-PHENYL-N'-(PYRIDINYL-N-OXIDE)UREA PLANT REGULATORS. | FMC CORP (US) | 1985-07-30 | — | — | EP | disclosed |
| EP-0144230-A2 | Growth promotants for animals | Pfizer Limited (GB) | 1985-06-12 | — | — | EP | disclosed |
| EP-0138983-A1 | N-PHENYL-N'-(PYRIDINYL-N-OXIDE)UREA PLANT REGULATORS. | FMC CORP (US) | 1985-05-02 | — | — | EP | disclosed |
| WO-1984003884-A1 | N-PHENYL-N'-(PYRIDINYL-N-OXIDE)UREA PLANT REGULATORS | FMC CORP (US) | 1984-10-11 | — | — | WO | disclosed |
| US-3966741-A | Process for the preparation of substituted or unsubstituted 4-pyridylthioacetic acid | OCE-ANDENO B.V. (NL) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326709-A1 | THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS | NAAA, OAT, PAM | TSHR 2874/4885ALDH1A1 1504/4885TDP1 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.